Document is current
Any future updates will be listed below
-
Authors
Fitzjerrells, Rachel L. https://orcid.org/0000-0001-8788-0984
Meza, Leeann Aguilar
Yadav, Meeta
Olalde, Heena
Hoang, Jemmie
Paullus, Mishelle
Cherwin, Catherine
Cho, Tracey A.
Brown, Grant
Ganesan, Sukirth M.
Mangalam, Ashutosh K. https://orcid.org/0000-0002-9926-2531
-
Funding
Funding for this research was provided by:
National Institute of Dental and Craniofacial Research (F31DE033564, T90DE023520, R03DE030527)
National Institute of Nursing Research (1P20NR018081-01)
National Institute of Allergy and Infectious Diseases (1RO1AI137075)
U.S. Department of Veterans Affairs (1I01CX002212)
National Institute of Environmental Health Sciences (P30 ES005605)
Gift from P. Heppelmann and M. Wacek
Carver Trust Pilot Grant
- License Information
-
More Information
Article History
Received: 12 December 2024
Accepted: 14 July 2025
First Online: 20 October 2025
Competing interests
: A.K.M. is one of the inventors of a technology claiming the use of Prevotella histicola to treat autoimmune diseases. A.K.M. received royalties from Mayo Clinic (paid by Evelo Biosciences). However, no fund or product from the patent were used in the present study. All other authors declare no commercial or financial relationships that could be a potential conflict of interest.
